{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:23:16Z","timestamp":1745763796144},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T00:00:00Z","timestamp":1327968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s12185-012-1012-2","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T15:56:28Z","timestamp":1327938988000},"page":"311-314","source":"Crossref","is-referenced-by-count":10,"title":["Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia"],"prefix":"10.1007","volume":"95","author":[{"given":"Aruna","family":"Gavini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys H.","family":"Telang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,31]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33:1065\u20137.","journal-title":"Arthritis Rheum"},{"key":"1012_CR2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","volume":"80","author":"M Dungarwalla","year":"2008","unstructured":"Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol. 2008;80:469\u201376.","journal-title":"Eur J Haematol"},{"key":"1012_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","volume":"115","author":"E Schlette","year":"2001","unstructured":"Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001;115:571\u201381.","journal-title":"Am J Clin Pathol"},{"key":"1012_CR4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V89.6.2015","volume":"89","author":"D Lens","year":"1997","unstructured":"Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, et al. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 1997;89:2015\u201323.","journal-title":"Blood"},{"key":"1012_CR5","first-page":"RA69","volume":"13","author":"T Robak","year":"2007","unstructured":"Robak T, Robak P. Current treatment options in prolymphocytic leukemia. Med Sci Monit. 2007;13:RA69\u201380.","journal-title":"Med Sci Monit"},{"key":"1012_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1078-0432.CCR-07-1061","volume":"14","author":"LM Leoni","year":"2008","unstructured":"Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J, et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008;14:309\u201317.","journal-title":"Clin Cancer Res"},{"key":"1012_CR7","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1200\/JCO.2008.20.8389","volume":"27","author":"WU Knauf","year":"2009","unstructured":"Knauf WU, Lissichkov T, Aldaoud A, Liberati A, Loscertales J, Herbrecht R, et al. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol. 2009;27:4378\u201384.","journal-title":"J Clin Oncol"},{"key":"1012_CR8","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1158\/1078-0432.CCR-08-0388","volume":"14","author":"G Rou\u00e9","year":"2008","unstructured":"Rou\u00e9 G, L\u00f3pez-Guerra M, Milpied P, P\u00e9rez-Gal\u00e1n P, Villamor N, Montserrat E, et al. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling. Clin Cancer Res. 2008;14:6907\u201315.","journal-title":"Clin Cancer Res"},{"key":"1012_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/asheducation-2010.1.481","volume":"2010","author":"S Stilgenbauer","year":"2010","unstructured":"Stilgenbauer S, Zenz T. Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:481\u20138.","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"1012_CR10","unstructured":"Treanda [package insert]. Frazer: Cephalon, Inc.; 2008."},{"key":"1012_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jcp.2008.058289","volume":"62","author":"PK Ramdial","year":"2009","unstructured":"Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62:493\u2013504.","journal-title":"J Clin Pathol"},{"key":"1012_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03703.x","volume":"71","author":"MR Ardern-Jones","year":"2011","unstructured":"Ardern-Jones MR, Friedmann PS. Skin manifestations of drug allergy. Br J Clin Pharmacol. 2011;71:672\u201383.","journal-title":"Br J Clin Pharmacol"},{"key":"1012_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D385N6C9JF","volume":"16","author":"HS Alamdari","year":"2010","unstructured":"Alamdari HS, Pinter-Brown L, Cassarino DS, Chiu MW. Severe cutaneous interface drug eruption associated with bendamustine. Dermatol Online J. 2010;16:1.","journal-title":"Dermatol Online J"},{"key":"1012_CR14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2008.09.015","volume":"59","author":"D Gerson","year":"2008","unstructured":"Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: a 5-year experience. J Am Acad Dermatol. 2008;59:995\u20139.","journal-title":"J Am Acad Dermatol."},{"key":"1012_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0738-081X(99)00058-9","volume":"17","author":"I Ghersetich","year":"1999","unstructured":"Ghersetich I, Comacchi C, Jorizzo JL, Katsambas A, Lotti TM. Proposal for a working classification of cutaneous vasculitis. Clin Dermatol. 1999;17:499\u2013503.","journal-title":"Clin Dermatol"},{"key":"1012_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0738-081X(99)00059-0","volume":"17","author":"G Hautmann","year":"1999","unstructured":"Hautmann G, Campanile G, Lotti TM. The many faces of cutaneous vasculitis. Clin Dermatol. 1999;17:515\u201331.","journal-title":"Clin Dermatol"},{"key":"1012_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","volume":"36","author":"SA Walsh","year":"2011","unstructured":"Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36:6\u201311.","journal-title":"Clin Exp Dermatol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1012-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T07:55:29Z","timestamp":1640591729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,31]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1012-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,31]]}}}